Literature DB >> 2866354

Does chloroquine contribute to the risk of serious adverse reactions to fansidar?

L Rombo, J Stenbeck, H O Lobel, C C Campbell, M Papaioanou, K D Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2866354     DOI： 10.1016/s0140-6736(85)91574-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs.

Authors:  P A Phillips-Howard; A B Bjorkman
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Development of recommendations for the protection of short-stay travellers to malaria endemic areas: Memorandum from two WHO Meetings.

Authors: 
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

Review 3.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

Review 4.  Prevention of malaria.

Authors:  J S Keystone
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 5.  Antimalarial drugs. An update.

Authors:  D C Warhurst
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

6.  How frequent are notified severe cutaneous adverse reactions to Fansidar?

Authors:  D Stürchler; M L Mittelholzer; L Kerr
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

7.  Pyrimethamine-sulphadoxine: how great the risk?

Authors:  D Stürchler
Journal:  J R Soc Med       Date:  1990-09       Impact factor: 18.000

8.  Synthesis and antimalarial evaluation of cyclic beta-amino acid-containing dipeptides.

Authors:  Manisha Sathe; Duraipandian Thavaselvam; Ashish Kumar Srivastava; Mahabir Parshad Kaushik
Journal:  Molecules       Date:  2008-02-18       Impact factor: 4.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.